Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4162610

N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)N(Cc1cnc2ccccc2c1)C(=O)CNC(=O)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
GCG P01275 1/20 0.34
MCHR1 Q99705 1/20 0.34
OPRK1 P41145 5/20 0.34
TPH1 P17752 1/20 0.33
KDR P35968 1/20 0.33
CES1 P23141 1/20 0.33
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
GABRA1 P14867 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.32
PPARD Q03181 1/20 0.32
CFTR P13569 1/20 0.32
ADCY6 O43306 1/20 0.32
ADCY3 O60266 1/20 0.32
ADCY9 O60503 1/20 0.32
ADCY5 O95622 1/20 0.32
ADCY8 P40145 1/20 0.32
GCGR P47871 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4162613 0.85 MCHR1 (0.35) HDAC1HDAC2GCGMCHR1OPRK1
Trifluoroacetic Acid SCHEMBL3502968 0.78 POLQ (0.36) HDAC1HDAC2CES1KMT2A
SCHEMBL4151724 0.77 MCHR1 (0.41) HDAC1HDAC2MCHR1OPRK1TPH1
Trifluoroacetic Acid SCHEMBL4156590 0.73 SIRT2 (0.41) HDAC1HDAC2MCHR1OPRK1TPH1
Trifluoroacetic Acid SCHEMBL4163744 0.71 HDAC1 (0.34) HDAC1HDAC2CES1GABRA1TRPM8
SCHEMBL4151722 0.70 SIRT2 (0.41) HDAC1HDAC2MCHR1TPH1CES1
Trifluoroacetic Acid SCHEMBL4166172 0.69 SIRT2 (0.41) HDAC1HDAC2MCHR1OPRK1TPH1
Trifluoroacetic Acid SCHEMBL4151861 0.69 NPC1 (0.33) HDAC1HDAC2CES1GABRA1TRPM8
Trifluoroacetic Acid SCHEMBL4166154 0.68 SIRT2 (0.38) HDAC1HDAC2MCHR1OPRK1TPH1
SCHEMBL3507608 0.68 CES1 (0.36) HDAC1HDAC2CES1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 HDAC1 2/4885HDAC2 7/4885GCG 2439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.